Evidence map›Paper›PMID 31993293›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2020

Developmentally Engineered Callus Organoid Bioassemblies Exhibit Predictive In Vivo Long Bone Healing.

Gabriella Nilsson Hall, Luís Freitas Mendes, Charikleia Gklava, Liesbet Geris, Frank P Luyten, Ioannis Papantoniou

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 207 citations in OpenAlex.

  1. Bone organoids and mitochondrial reprogramming.Journal of orthopaedic translation · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Bone Organoids: A Novel Tool for Modeling and Managing Skeletal Disorders in Diabetes.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Gabriella Nilsson HallPrometheus Division of Skeletal Tissue Engineering Skeletal Biology and Engineering Research Center Department of Development and Regeneration KU Leuven O&N1, Herestraat 49, PB 813 3000 Leuven Belgium.ORCID https://orcid.org/0000-0001-7803-652X
Luís Freitas MendesPrometheus Division of Skeletal Tissue Engineering Skeletal Biology and Engineering Research Center Department of Development and Regeneration KU Leuven O&N1, Herestraat 49, PB 813 3000 Leuven Belgium.
Charikleia GklavaPrometheus Division of Skeletal Tissue Engineering Skeletal Biology and Engineering Research Center Department of Development and Regeneration KU Leuven O&N1, Herestraat 49, PB 813 3000 Leuven Belgium.
Liesbet GerisPrometheus Division of Skeletal Tissue Engineering KU Leuven O&N1, Herestraat 49, PB 813 3000 Leuven Belgium.ORCID https://orcid.org/0000-0002-8180-1445
Frank P LuytenPrometheus Division of Skeletal Tissue Engineering Skeletal Biology and Engineering Research Center Department of Development and Regeneration KU Leuven O&N1, Herestraat 49, PB 813 3000 Leuven Belgium.ORCID https://orcid.org/0000-0003-3186-0276
Ioannis PapantoniouPrometheus Division of Skeletal Tissue Engineering Skeletal Biology and Engineering Research Center Department of Development and Regeneration KU Leuven O&N1, Herestraat 49, PB 813 3000 Leuven Belgium.ORCID https://orcid.org/0000-0002-4754-5492
Prometheus Research (United States) · USUniversity of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical translation of cell-based products is hampered by their limited predictive in vivo performance. To overcome this hurdle, engineering strategies advocate to fabricate tissue products through processes that mimic development and regeneration, a strategy applicable for the healing of large bone defects, an unmet medical need. Natural fracture healing occurs through the formation of a cartilage intermediate, termed "soft callus," which is transformed into bone following a process that recapitulates developmental events. The main contributors to the soft callus are cells derived from the periosteum, containing potent skeletal stem cells. Herein, cells derived from human periosteum are used for the scalable production of microspheroids that are differentiated into callus organoids. The organoids attain autonomy and exhibit the capacity to form ectopic bone microorgans in vivo. This potency is linked to specific gene signatures mimicking those found in developing and healing long bones. Furthermore, callus organoids spontaneously bioassemble in vitro into large engineered tissues able to heal murine critical-sized long bone defects. The regenerated bone exhibits similar morphological properties to those of native tibia. These callus organoids can be viewed as a living "bio-ink" allowing bottom-up manufacturing of multimodular tissues with complex geometric features and inbuilt quality attributes.

Indexed as

developmental engineeringendochondral ossificationlong‐bone defectorganoidtissue engineering

Identifiers

PMID31993293
PMCPMC6974953
OpenAlexW2994778858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.